Stay updated on Immunotherapy Addition in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Addition in Lung Cancer Clinical Trial page.

Latest updates to the Immunotherapy Addition in Lung Cancer Clinical Trial page
- Check7 days agoChange DetectedOn 2026-07-06, the record history adds Contacts/Locations and an updated Study Status, with an update identifier 961.SummaryDifference0.0%

- Check14 days agoChange DetectedThe record history adds new version entries (960 on 2026-07-02 and 959 on 2026-06-30) that update the Study Status and Contacts/Locations sections and update the overall revision to v3.6.3. This signals refreshed status and contact/site information for the trial within the official record.SummaryDifference0.1%

- Check22 days agoChange DetectedThe study's record history now includes a new 2026-06-23 revision (v3.6.0) with additional UI-related change notes, replacing the prior 2026-06-03 entry for v3.5.5 and updating the revision trail.SummaryDifference0.2%

- Check38 days agoChange DetectedA new revision (v3.5.5) was added on 2026-06-03, introducing updated Study Status and Contacts/Locations sections. The update replaces the previous revision (v3.5.4) and adds the related history entries for this version.SummaryDifference0.1%

- Check45 days agoChange DetectedNew revisions were added to the record history on 2026-05-29, introducing updates to the Study Status and Contacts/Locations sections. These entries include revision numbers 944–947, reflecting ongoing updates to the trial record.SummaryDifference0.1%

- Check53 days agoChange DetectedThe version history gains a new entry on 2026-05-22 that adds Study Status and Contacts/Locations to the record, with related newer versions (941–943) appearing around mid‑May 2026 and a deletion on 2026-05-15.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy Addition in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Addition in Lung Cancer Clinical Trial page.